$1.41
-0.14-9.03%
Últ. Act.: Nov 6, 9:30 AM
The average analyst price target for Alzamend Neuro is $26, 1475.8% above the current price. The one analyst covering it rates it Buy. The latest change came on Aug 19, 2026, when Ascendiant Capital raised its price target on Alzamend Neuro from $25 to $26 and kept a Buy rating.
Price Target Range — 5 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months